 |
| Global Bone Marrow Transplant Market Size |
Bone marrow transplant involves replacing unhealthy bone marrow with healthy
bone marrow stem cells. It is a treatment option for various blood cancers like
leukemia, lymphoma and multiple myeloma. Advanced bone marrow transplant
therapies help improve outcomes for patients requiring high-dose chemotherapy
by extracting stem cells from bloodstream or bone marrow and transferring them
back after treatment.
The global
Bone Marrow Transplant Market is estimated to be valued at US$ 7261.28 Mn in 2023 and is expected to exhibit a CAGR of 6.7% over the forecast period
2024 to 2031, as highlighted in a new report published by Coherent Market
Insights.
Market key trends:
The adoption of advanced bone marrow transplant therapies is one of the key
trends driving the market growth. Advanced therapies like reduced intensity
conditioning allow patients who are not eligible for high-dose chemotherapy to
receive stem cell transplants. They help reduce rejection risks and
transplant-related complications. Technologies that help extract larger number
of stem cells from donor in single harvest are also gaining popularity.
Emerging cell therapies utilizing mesenchymal stem cells or genetically
modified T-cells demonstrate potential to treat more types of cancers.
Continuous development of novel approaches will further augment the market over
the forecast period.
Segment Analysis
Autologous bone marrow transplant accounts for most of the market share as it
is preferred for treating blood cancers like leukemia, myeloma, and lymphoma.
This is because autologous stem cells are collected from the patient's own body
which reduces the risk of graft rejection. The procedure carries less
complication than allogeneic transplant as donor matching is not required.
Key Takeaways
Global
Bone Marrow Transplant Market Size is expected to witness high growth.
The global Bone Marrow Transplant Market is estimated to be valued at US$ 7261.28 Mn in 2023 and is expected
to exhibit a CAGR of 6.7% over the
forecast period 2024 to 2031.
Regional analysis
North America holds the dominant share due to the increasing prevalence of
blood cancers such as leukemia, lymphomas, and myelomas. The US leads the
market owing to advanced healthcare infrastructure and high adoption of bone
marrow transplant procedures. The increasing awareness about transplantation
and supportive government regulations also contribute to market growth.
Key players
Key players operating in the Bone Marrow Transplant market are Shenzhen Mindray
Bio-Medical Electronics Co., Ltd., Getinge AB, General Electric Company,
Hamilton Medical, Medtronic, ICU Medical, Inc., Dragerwerk AG & Co. KGaA,
ZOLL Medical Corporation, Koninklijke Philips N.V., VYAIRE, Fisher & Paykel
Healthcare Limited, ResMed, Max Ventilator (A.B.Industries), NIHON KOHDEN
CORPORATION, Inspiration Healthcare Group plc., CorVent Medical Inc., Inovytec,
InnAccel Technologies Pvt Ltd., and OES Medical.
Get More Insights On This Topic: https://www.ukwebwire.com/bone-marrow-transplant-market-analysis/
Explore More Related Article: https://businessinmyarea.com/latest/powering-the-future--a-comprehensive-analysis-of-the-system-on-a-chip--soc--market-landscape